Evolus, Inc. (EOLS)
4.45
+0.12
(+2.77%)
USD |
NASDAQ |
Apr 14, 16:00
4.45
0.00 (0.00%)
After-Hours: 20:00
Evolus Cash from Investing (TTM) : -8.452M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Anika Therapeutics, Inc. | -0.401M |
| STAAR Surgical Co. | 46.34M |
| Sanara MedTech, Inc. | -14.97M |
| Quantum-Si, Inc. | -28.32M |
| Plus Therapeutics, Inc. | -0.854M |